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Introduction
Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by social communication deficits and restricted repetitive behaviors (Lord and Bishop, 2015) , and it is frequent associated with intellectual disability (ID), language deficits and seizures (Geschwind, 2009; Sztainberg and Zoghbi, 2016) . The causes of ASD remain largely unknown, although a genetic cause has been identified in around 25% of cases (Huguet et al., 2013) . These genetic alterations include chromosomal rearrangements, de novo copy-number variants and de novo mutations in the coding-sequence of genes associated with chromatin remodeling, mRNA translation or synaptic function (de la Torre-Ubieta et al., 2016) . Additionally, alterations in the production or migration of neocortical neurons are a point of convergence for ASD and ID (de la Torre-Ubieta et al., 2016; Ernst, 2016; Packer, 2016) .
DYRK1A is a member of the conserved dual-specificity tyrosine-regulated kinase (DYRK) family of protein kinases (Aranda et al., 2011 ) that has different functions in the nervous system (Tejedor and Hammerle, 2011) . This kinase influences brain growth, an activity that is conserved across evolution (Fotaki et al., 2002; Kim et al., 2017; Tejedor et al., 1995) . DYRK1A is located within the Down syndrome (DS) critical region on human chromosome 21 (Guimera et al., 1996) .
There is evidence that triplication of the gene contributes to neurogenic cortical defects (Najas et al., 2015) and other neurological deficits in DS, making it a potential drug target for DS-associated neuropathologies (Becker et al., 2014) . Recently, mutations in DYRK1A have been identified in a recognizable syndromic disorder named DYRK1A haploinsufficiency syndrome (DHS), also known as MRD7 (Mental Retardation Autosomal Dominant 7; OMIM: 614104) and DYRK1A-related intellectual disability syndrome (ORPHANET: 464306, 464311 and 268261) . ASD-related deficits are common clinical manifestations in DHS, which include moderate to severe ID, intrauterine growth retardation, developmental delay, microcephaly, seizures, speech problems, motor gait disturbances and a dysmorphic facies (Earl et Luco et al., 2016; van Bon et al., 2016) . The mutations identified to date in patients with DHS are de novo, involving chromosomal rearrangements (Courcet et al., 2012; Moller et al., 2008; van Bon et al., 2011) , small insertions or deletions, and nonsense mutations (Courcet et al., 2012; Earl et al., 2017; O'Roak et al., 2012; van Bon et al., 2016) and references therein). These mutations lead to the production of truncated DYRK1A proteins that lack partially o totally the kinase domain and that are therefore catalytically inactive. DYRK1A missense mutations have also been identified in patients with a distinctive DHS phenotype (Bronicki et al., 2015; Dang et al., 2018; De Rubeis et al., 2014; Deciphering Developmental Disorders, 2015; Evers et al., 2017; Ji et al., 2015; Ruaud et al., 2015; Stessman et al., 2017; Trujillano et al., 2017; Wang et al., 2016; Zhang et al., 2015) . The structural modeling of these mutations predicts that they are loss-of-function (LoF) mutations (Evers et al., 2017; Ji et al., 2015) . However, experimental data supporting this prediction have been reported only for a few of them (Widowati et al., 2018) .
ACCEPTED MANUSCRIPT

A C C E P T E D M A N U S C R I P T
The Dyrk1a +/-mouse displays some of the core traits of DHS, including developmental delay, microcephaly, gait disturbances and learning problems (Arque et al., 2008; Fotaki et al., 2002; Fotaki et al., 2004) . The cell density in the neocortex of the adult mutant mouse is altered (Fotaki et al., 2002; Guedj et al., 2012) but the origin of this alteration and the neuronal components affected are unknown. To gain additional insight into the pathogenesis of DHS, we have performed a biochemical study to assess the impact of all reported missense mutations within the catalytic domain on DYRK1A activity. Furthermore, we analyzed the cytoarchitecture and gene expression profile of the neocortex in Dyrk1a +/-mice, also performing behavioral tests and obtaining electroencephalogram (EEG) recordings from these animals. Our results indicate that defects in the production of excitatory neocortical neurons are critical to the neuropathology of DHS.
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Materials and methods
Plasmids
The plasmids to express HA-tagged DYRK1A have been described previously (Alvarez et al., 2003) Table 2 ). The A469fs* and A489fs* mutations were produced by a T or C deletion, respectively, and the same alterations were created in the DYRK1A expression plasmid. The plasmids generated by site-directed mutagenesis were verified by DNA sequencing and the transfection efficiency was assessed by cotransfection with a green fluorescent protein (GFP) expression plasmid (pEGFP-C1, Clontech).
Animals
We used embryos and postnatal and adult Dyrk1a +/-mice and their control Dyrk1a
littermates, generated and genotyped as described elsewhere (Fotaki et al., 2002; Najas et al., 2015) . The day of the vaginal plug was defined as E0 and the day of birth was defined as P0. After weaning, mice from the same litter and of the same gender were housed in groups. The animals were maintained at the PCB-PRBB Animal Facility in ventilated cages on a 12 h light/dark cycle, at approximately 20C and in 60% humidity, and with food and water supplied ad libitum. For bromodeoxyuridine (BrdU) birthdating experiments, pregnant females were peritoneally injected with a BrdU solution (50 mg/kg; Sigma), two injections spaced 4
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h, and pups were collected and processed at P7. Experimental procedures were carried out in accordance with the European Union guidelines (Directive 2010/63/EU) and the protocols were approved by the Ethics Committee of the CSIC, PCB-PRBB, CBM and Fundación Jiménez Díaz.
Cell culture and transfection
The HEK293T cell line was obtained from the American Type Culture Collection (www.atcc.org) and used for the exogenous expression of DYRK1A mutants. The cells were maintained at 37ºC in Dulbecco´s modified Eagle medium (DMEM; Invitrogen), with 10% fetal bovine serum (FBS; Invitrogen) and supplemented with antibiotics (100 g/ml penicillin and 100 g/ml streptomycin; Invitrogen). The cells were transfected by the calcium phosphate precipitation method and processed 48 h after transfection. 
In vitro kinase (IVK) assays
Video-EEG recordings
Video-EEG recordings of adult Dyrk1a +/+ and Dyrk1a +/-male mice (8 animals each genotype) aged 5-6 months were obtained as described elsewhere (Garcia-Cabrero et al., 2012) . Two home-made EEG stainless steel electrodes were implanted symmetrically into an anesthetized mouse over the cortex in front of bregma, and the ground and reference electrodes were placed posterior to lambda (Fig. 2C) . A plastic
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A C C E P T E D M A N U S C R I P T pedestal (Plastic One Inc., Roanoke, VA, USA) was used to attach the pins of the electrodes, and the headset was fixed to the skull and the wound closed with dental cement (Selectaplus CN, Dentsply DeTrey GmbH, Dreireich, Germany). Four days after surgery, synchronized video-EEG activity was recorded for 48 h in freely moving mice using a computer-based system (Natus Neurowork EEG, Natus Medical
Inc., San Carlos, CA, USA). EEG seizure activity was examined by inspecting the entire EEG records and behavioral correlations were reviewed within the corresponding video-type segments.
Behavioral Tests
The social and stereotyped behaviors (social interaction and marble-burying tests) of adult 4-6 month old Dyrk1a +/+ and Dyrk1a +/-male mice (12-15 animals each genotype) were tested in a dedicated room for behavioral studies during the light phase. Before the experiment, the animals were habituated to the room for at least 30 min and during the test, the mice were recorded from above with a video-camera CCTV (Sonny Corporation). The animal's behavior was analyzed by an observer blind to their genotype using the SMART 3.0 software (Panlab Harvard Apparatus).
See Supplementary Materials and Methods for more details on these procedures as well as for the UsV analysis.
Tissue preparation, immunostaining, and cell and synapse counts
To obtain brain tissue, P7 and adult Dyrk1a +/+ and Dyrk1a +/-mice (4-9 animals each condition) were deeply anesthetized and transcardially perfused with 4%
paraformaldehyde. The mouse's brain was removed and post-fixed, and cryotome or vibratome brain sections were immunostained as described previously (Barallobre et al., 2014) . To quantify neurons and synapses, images were obtained on a Leica AF6500 motorized wide-field microscope and a Zeiss LSM780 confocal microscope, respectively. To quantify BrdU-labeled cells, images were obtained on an Olympus
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BX51 motorized microscope with a JVC digital color camera. The procedures for immunostaining, and cell and synapse quantification are indicated in the Supplementary Materials and Methods. The source of the primary antibodies for these procedures is indicated in Supplementary Table 6 .
Statistical analysis
Statistical analyses were performed with GraphPad Prism v5.0a (GraphPad Software) or with SPSS (IBM Analytics Software). The data from the IVK studies were analyzed with a 2-tailed unpaired Mann-Whitney test, synapse counts with a nested one-way ANOVA test, and the rest of the analysis was performed with a twotailed unpaired Student's t-test. Differences were considered significant at p < 0.05.
In the histograms, the data are represented as the mean  standard error of the mean (SEM).
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Results
DYRK1A missense mutations in individuals with DYRK1A haploinsufficiency are loss-of-function mutations
The kinase activity associated with most of DYRK1A missense mutations has been inferred from their position within the DYRK1A catalytic domain (Evers et al., 2017) .
Given that experimental data supporting the predicted models have been reported very recently for only a few DYRK1A missense mutations (Widowati et al., 2018) , we set out to analyze the kinase activity of all missense mutations within the DYRK1A catalytic domain published to date and some others included in the ClinVar database (www.ncbi.nlm.nih.gov/clinvar/?term=DYRK1A[gene]). We also included 2 missense mutations in the non-catalytic C-terminal region (R528W and T588N) and 3 mutations generating truncated proteins at the end of the kinase domain and predicted to contain the whole catalytic domain (Fig. 1A , Table 1 and Supplementary   Table 1 ). These mutations were introduced into a DYRK1A expression plasmid and the catalytic activity of each of the mutants was evaluated using an IVK assay with the DYRKtide peptide as the substrate (see experimental design in Fig. 1B ). The activity of most of the missense mutants was comparable to that of the DYRK1A K188R kinase-dead mutant ( Fig. 1C) , although the L295F, Q313H and R438H mutants rendered proteins with half the activity of the WT protein (Fig. 1C) . However, some of the mutations did not alter the DYRK1A catalytic activity (K167R and T588N), and six even enhanced the enzyme's kinase activity: A195T, H223R, L259F, R458M, G486D and R528W (Fig. 1C) . Notably, the activity of the truncated proteins increased with the length of the resulting protein, with truncations at R467 (before the -helix I) devoid of activity, and at F478 (downstream -helix I) with just 10% activity (Fig. 1C) . Moreover, the fact that the A498Pfs93* mutant does not have similar catalytic activity to the WT protein might indicate that all or part of the non-catalytic C-terminal region is required for full DYRK1A kinase activity. Of note, the crystal ACCEPTED MANUSCRIPT
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structures of DYRK1A have been obtained with truncated proteins that, based on our data, are not fully active (Soundararajan et al., 2013) .
Considering the mode of activation of DYRK1A (Lochhead et al., 2005) , the negative results in the IVK assays could be due to defective autophosphorylation of the Tyr residue in the activation loop, or to the inability of the mutants to phosphorylate an exogenous substrate. The lack of activity on the substrate was correlated with a lack of Tyr phosphorylation ( Fig. 1D) , suggesting that the mutations altered the activation of the kinase. We also evaluated the autophosphorylation of the mutant proteins (Fig. 1B) , an activity associated with the mature kinase (Himpel et al., 2001) , and only the catalytically active mutant enzymes were seen to autophosphorylate, with the exception of the truncated mutant A498Pfs93* ( Fig. 1D and Supplementary Fig. 1A and B). In this latter case, either the autophosphorylation sites are located in the missing C-terminal region or the mutation alters the substrate preference of the protein. Together, these results indicate that most but not all of the missense DYRK1A mutants reported to date in DHS are bona-fide LoF mutants.
There is deficient accumulation of the kinase-dead DYRK1A K188R mutant (Kii et al., 2016) and therefore, we evaluated the quantitative expression of these mutants and their stability ( Fig. 1E : stability index). We confirmed the reduced accumulation of the K188R mutant relative to the WT protein (Fig. 1F) , and a similar behavior was observed for other catalytically inactive mutants ( Fig. 1F and Supplementary Fig. 1C ). In fact, kinase activity and protein stability were positively correlated ( Fig. 1G ), suggesting that in heterozygosis, the proteins expressed from the mutant allele will not accumulate as much as the WT protein, thereby reducing their potential dominant-negative activity.
Stereotyped behavior and epileptic activity of Dyrk1a +/-mice
Seizures, stereotypies and social anxiety are frequent in DHS (Earl et al., 2017; van Bon et al., 2016) . The Dyrk1a +/-mouse is more sensitive to the convulsive agent
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pentylenetetrazol (Souchet et al., 2014) and it displays anxiety-like behavior in the open field (Fotaki et al., 2004) , although ASD-like behaviors and epileptiform activity have not been reported in this model. Recently, a mouse carrying a frame-shift mutation in Dyrk1a has been generated and mice heterozygous for this mutation develop deficits in social contacts and communicative ultrasonic vocalization (UsV), as well as hyperthermia-induced seizures (Raveau et al., 2018) . Dyrk1a +/-pups displayed similar deficits in UsV when separated from their mothers (Supplementary Fig. 2A ). Moreover, adult Dyrk1a +/-mice engaged in shorter social olfactory interactions (oral-oral or oral-genital sniffing) in the resident-intruder test, while more time was spent on repetitive digging and self-grooming ( Fig. 2A) The epileptic activity in Dyrk1a +/-mice was evaluated from video-EGG recordings ( Fig. 2C-H) , which revealed differences in the basal activity between the distinct genotypes (Dyrk1a +/+ 9-12 Hz; Dyrk1a +/-6-7 Hz: Fig. 2D ). Spontaneous myoclonic jerks that corresponded to interictal epileptiform activity were evident in Dyrk1a +/-mice, with isolated spikes, polyspikes and spike-wave discharges (Fig. 2E-G ). These mutant mice also experienced periods of immobility, during which
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A C C E P T E D M A N U S C R I P T grooming, feeding and exploration were suppressed. Such periods of inactivity, alternating with shorter ones of epileptic activity, were characterized by groups of spikes and polyspikes in the EEG recordings ( Fig. 2E and F Thus, epileptic activity seems to be a common characteristic in humans and mice with DHS.
Alterations in neuron numbers in the developing neocortex of Dyrk1a
The neocortex is a six-layered structure essential for higher cognitive functions and sensory perception. Most neocortical neurons (more than 80% in the mouse) are projection excitatory neurons that extend their axons to intracortical or subcortical targets and use glutamate as neurotransmitter. The distinct types of excitatory neurons are produced in the embryo dorsal telencephalon (from E11.5 to E17.5 in the mouse) in overlapping temporal waves. The first neurons formed are those that are closest to the ventricle (layer VI neurons) and the last formed are those neurons located in the most superficial layers (layers II-III neurons) (Florio and Huttner, 2014; Molyneaux et al., 2007) . Of note, perturbations in sensory regions and in the circuits that connect these regions have been described in several ASD mouse models (Golden et al., 2018) . We previously showed that production of the early-born cortical neurons is enhanced in Dyrk1a +/-embryos (Najas et al., 2015) . To obtain further evidence as to how Dyrk1a haploinsufficiency affects cortical development, we ACCEPTED MANUSCRIPT
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counted the number of neurons that express the neuronal marker NeuN in the internal (V-VI) and external (II-IV) layers of the somatosensory cortex (SSC) at P7 (Fig. 3A) , when radial migration has ended and excitatory neurons adopt their final positions (Miller, 1995) . The neocortical layers were thinner in postnatal Dyrk1a +/-mice, while they contained more neurons than their Dyrk1a +/+ littermates ( Fig. 3B and   C ). The fact that the neuronal densities in the internal and external layers of Dyrk1a +/-mutants are similarly affected (Fig. 3C) suggests that Dyrk1a haploinsufficiency may alter neuron production along the neurogenic phase of cortical development. This possibility was evaluated with BrdU-birthdating analysis (Fig. 3D-F when the treatment was performed at E15.5 (Fig. 3F) . Additional BrdU-labeling experiments indicated that cortical neurogenesis in Dyrk1a +/-embryos ends at the correct time ( Supplementary Fig. 4) . Consistent with the temporal generation of cortical excitatory neurons (Molyneaux et al., 2007) , the BrdU-labeled cells generated at E15.5 were concentrated in the external layers of P7 WT animals, while the labeled cells generated at E13.5 showed a broader layer distribution, with BrdU + cells located in both internal and external layers ( Fig. 3E and G) . Additionally, the distribution of BrdU-labeled cells in Dyrk1a +/-animals was similar to that in WT animals ( Fig. 3E and G) , indicating that radial migration of excitatory neurons is not affected in the Dyrk1a +/-model. Taking all the results together, we conclude that the augmented neuron density in the neocortex of Dyrk1a +/-mutants is the result of an increased neuron production during early and mid-corticogenesis.
Finally, the differentiation of excitatory neurons was assessed by studying the layer-specific markers Ctip2 (layer V) and Mef2c (layers II-IV 
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A C C E P T E D M A N U S C R I P T 3B and C). As the distinct types of neocortical excitatory neurons display different
electrophysiological properties and project to distinct target areas (Molyneaux et al., 2007) , the alteration in the proportions of these neurons could modify the final wiring of the brain in the Dyrk1a +/-mutants.
Alterations to the synaptic circuitry in the neocortex of adult Dyrk1a +/-mice
Around 10-15% of neocortical neurons are interneurons that make local connections and use -aminobutyric acid (GABA) as a neurotransmitter (Markram et al., 2004) .
These neurons maintain the stability of cortical networks and they modulate network activity through synaptic inhibition (Somogyi et al., 1998) . In fact, disturbances to the excitation/inhibition ratio (E/I imbalance) in relevant brain circuits have been proposed as a common pathogenic mechanism in ASD (Rubenstein, 2010) . Studies in ASD mouse models indicate that E/I imbalance may arise not only from changes in synapse function and homeostasis but also from an altered proportion of excitatory and inhibitory neurons (de la Torre-Ubieta et al., 2016).
We have previously shown that the brain of adult Dyrk1a +/-mice present altered levels of proteins related to the glutamatergic and GABAergic systems (Souchet et al., 2014) . Based on these data, we wondered whether the defects in cortical development displayed by the Dyrk1a +/-mice results in alterations in the adult circuitry. To this aim, we analyzed the excitatory (NeuN + /GABA -) and inhibitory (GABA + ) neurons in the SSC of adult animals ( Fig. 4A and B) . The number of excitatory neurons in Dyrk1a +/-mutants increased in both the internal and external neocortical layers. The heterozygous mice also had more GABAergic neurons than their WT littermates, although the difference between these genotypes was only significant in the internal layers (Fig. 4B) . The density of excitatory and inhibitory synapses was estimated in adult neocortices using antibodies against presynaptic markers VgluT1 (vesicular glutamate transporter 1) or VGAT (vesicular GABA transporter), and the postsynaptic markers Homer or Gephyrin. There was a
ACCEPTED MANUSCRIPT
A C C E P T E D M A N U S C R I P T
significant increase in excitatory synapses in Dyrk1a +/-mutants in the two layers examined (IV and VI), while the density of inhibitory synapses in the mutant mice was similar to that in WT animals ( Fig. 4C and D) . The alterations in the proportion of glutamatergic and GABAergic neurons and synapses observed in the Dyrk1a +/-neocortices may contribute to the ASD-related behavior and epileptic activity in these animals.
Transcriptome alterations in the postnatal Dyrk1a +/-cerebral cortex
The amount of Dyrk1a protein in the mouse developing neocortex increases during neurogenesis, reaching maximum levels in late embryonic development and during the first postnatal week (Dang et al., 2018) . At these developmental stages, neural precursors shift their status and become gliogenic (Kriegstein and Alvarez-Buylla, 2009), while neurons extend neurites and synaptogenesis begins (Li et al., 2010) .
These processes are coordinated by transcriptional programs that are dynamically regulated during development (Telley et al., 2016) , and it is possible that alterations to these programs might contribute to the early neurological phenotype in Dyrk1a haploinsufficiency. To test this possibility, we compared the transcriptional profile of the cerebral cortex in Dyrk1a +/+ and Dyrk1a +/-mice at P0 and P7 ( Supplementary Fig.   6A for the microarray experimental design and Fig. 5A for the comparisons performed). The comparison of the Dyrk1a expression profile during cortical development in Dyrk1a +/+ and Dyrk1a +/-mice confirmed that Dyrk1a expression was reduced by half in the cortices of Dyrk1a +/-mice at any time-point, reflecting Dyrk1a haploinsufficiency ( Supplementary Fig. 5 ).
The heatmap representation of the microarray expression data showed that the developmental effect on gene expression was more relevant than the effect of the reduction in Dyrk1a dose ( Supplementary Fig. 6B ). In fact, the analysis of genes differentially expressed between P7 and P0 in Dyrk1a +/-cortex showed numbers similar to the WT samples ( Fig. 5B ; see also Supplementary Fig. 7 for validation of ACCEPTED MANUSCRIPT
A C C E P T E D M A N U S C R I P T the microarray results and Supplementary Dataset 1)
. A large proportion of the genes that were differentially expressed during development in the WT samples changed in the same direction in Dyrk1a mutant samples ( Supplementary Fig. 6B ).
However, the expression of many of the genes that were up-regulated during development in the WT samples was diminished in Dyrk1a +/-samples and vice versa (Fig. 5C ). These results suggest that Dyrk1a haploinsufficiency does not have a strong impact on the transcriptional program that drives postnatal cortical development but rather, that it might affect the time-course of the repression/activation of transcription. Nevertheless, the expression of a subset of genes was significantly altered between the two genotypes at P0 (182 genes) or P7
(73 genes), with changes greater or less than 1.4 fold (Fig. 5D ).
Pathway enrichment analysis of the genes differentially expressed when comparing P0 and P7 WT cortices showed that the up-regulated genes at P7 were associated with synaptic transmission, while the down-regulated ones were enriched in cell cycle-associated functions ( Supplementary Fig. 8 ). These data are consistent with the developmental changes occurring in the neocortex, since differentiating neurons acquire terminal features. Indeed, at these stages most pluripotent progenitors in the ventricular zone lose their capacity to self-renew or become less proliferative, producing cells of the glial lineage (Kriegstein and Alvarez-Buylla,
2009). When analyzing the genes with transcriptional changes in the Dyrk1a
+/-samples compared to the WT ones, no particular enrichment was associated with the up-regulated genes in the Dyrk1a +/-animals, although known regulators of gliogenesis were identified in this set, such as Sox4 or Sox11 (Fig. 5E) , suggesting a possible defect in the onset of glial cell production in the Dyrk1a +/-mutant model. By contrast, the down-regulated set was enriched in genes whose products are located in dendrites (Calb1, Penk, Thy1) and/or that are involved in axon growth (Nefl, Nefm) or synaptic transmission (Gabra, Gabrg1, Htr: Fig. 5E and Supplementary Dataset ACCEPTED MANUSCRIPT
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2). Hence, the transcriptional alterations detected further support that neuron activity is altered in the neocortex of Dyrk1a +/-mutant pups.
Discussion
In this study, we analyzed a series of DYRK1A missense mutations, most of which are bona-fide LoF mutants that render the DYRK1A proteins enzymatically inactive.
Moreover, the positive correlation between activity and protein accumulation might indicate that the presence of kinase-dead proteins has an added harmful effect. Very recently, the analysis of several DYRK1A missense mutants found in humans has been published, with a focus on the biochemical properties of the kinase variants (Widowati et al., 2018) . Some of these variants are included in our analysis ( (Table 1 and Supplementary Table 1 ), suggesting that there is a threshold for DYRK1A activity regarding non pathological phenotypes.
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Somewhat unexpectedly, the enzymatic activity of several missense mutants was indistinguishable from that of the WT kinase (K167R, T588N) and in some cases, even an increment in activity was detected (A195T, H223R, L259F and R458M). No clinical information is available for some of these variants and therefore, no correlations can be established. For others, as the case of A195T, we cannot exclude that the activity of the mutants could be the reflection of an altered substrate choice; alternatively, they might lead to other alterations in DYRK1A function affecting its final biological activity with pathological consequences. A third possibility could be that they represent pathogenic variants of DYRK1A hyperactivity, based on the links of DYRK1A overexpression with certain DS pathological traits (Becker et al., 2014) . Of note, the hyperactive G486D mutation was identified in a patient with macrocephaly (Dang et al., 2018) , in contrast with the DHS patients with LoF mutations in which microcephaly is, generally, observed (Table 1) . Finally, the results might also mean that these mutations do not provoke any negative effects. Indeed, the effects of the catalytic missense A195T and L259F mutants have been evaluated in cultured cortical neurons, where their impact on neurite extension was similar to that of the WT neurons (Dang et al., 2018) . Therefore, in the case of the catalytically active mutants, the possibility that these genetic variants in the DYRK1A gene are not responsible for the clinical phenotype should also be considered.
In ASD and ID syndromes, alterations to dendrite morphogenesis and synapse formation are common (de la Torre-Ubieta et al., 2016) . There is evidence that DYRK1A regulates the actin cytoskeleton and microtubule dynamics, thereby contributing to the development and maintenance of neurites and dendritic spines (Martinez de Lagran et al., 2012; Ori-McKenney et al., 2016; Park et al., 2012) .
Indeed, the morphology of the dendritic arbor in neurons of the motor cortex is altered in Dyrk1a +/-mice and in transgenic mice overexpressing Dyrk1a (BenavidesPiccione et al., 2005; Martinez de Lagran et al., 2012) . These, together with the detrimental effect of DYRK1A truncated mutations in neuronal dendritic and spine
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A C C E P T E D M A N U S C R I P T growth (Dang et al., 2018) suggested that postnatal neocortical development is relevant to the neuropathology of DHS. However, our results indicate that Dyrk1a haploinsufficiency also affects neuron production in the developing neocortex leading to alterations to the number and proportion of the excitatory neuron subtypes.
Considering that each of the many distinct excitatory neural subtypes fulfills a particular function (Jabaudon, 2017) , subtle alterations in the proportion of these neurons would influence the activity of the synaptic circuits formed during postnatal development. In this context, the different transcriptomic profiles of the postnatal Dyrk1a +/-neocortex could be the consequence of its different neuronal composition.
However, given that DYRK1A can directly or indirectly regulate transcription (Aranda et al., 2011; Di Vona et al., 2015) , Dyrk1a haploinsufficiency might specifically modify the transcriptional programmes in differentiating neocortical neurons. In any case, the transcriptome analysis highlighted the weaker expression of genes involved in neuritogenesis and synaptic activity in the postnatal Dyrk1a +/-neocortex. Therefore, both the reduction in gene expression and the direct activity of DYRK1A on proteins implicated on neuritogenesis should be considered as factors that contribute to the neurological alterations in Dyrk1a +/-mutant mice.
Adult Dyrk1a +/-mice experience epileptic activity and behavior deficits similar to those observed in other ASD mouse models in which excitatory and/or inhibitory synaptic circuits are perturbed (Lee et al., 2017) . In fact, altered production and/or migration of excitatory and/or inhibitory cortical neurons affects the E/I balance in mature circuits, usually making them epileptogenic (Bozzi et al., 2012; Rubenstein, 2010) . Dyrk1a +/-mutants exhibit an excess of excitatory neurons and synapses in the neocortex, and these animals also show an excess of inhibitory neurons in the internal neocortical layers. Thus, we propose that both excitatory and inhibitory neurons contribute to the E/I imbalance underlying the epileptic activity, ASD-like behavior and cognitive deficits associated with DHS. A C C E P T E D M A N U S C R I P T 
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Figure Legends
